Advertisement
U.S. markets close in 28 minutes

Syndax Pharmaceuticals, Inc. (SNDX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Visitors trend2W10W9M
16.86+0.77 (+4.82%)
As of 03:32PM EST. Market open.
Advertisement
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
16,000
0
0
139,709
1,517
Operating Expense
337,212
229,954
151,757
113,489
72,940
Operating Income
-321,212
-229,954
-151,757
26,220
-71,423
Net Non Operating Interest Income Expense
24,346
20,955
2,735
-1,496
-1,516
Other Income Expense
-196
-361
-316
202
-219
Pretax Income
-297,062
-209,360
-149,338
24,926
-73,158
Net Income Common Stockholders
-297,062
-209,360
-149,338
24,926
-77,064
Diluted NI Available to Com Stockholders
-297,062
-209,360
-149,338
24,926
-77,064
Basic EPS
0.48
-2.98
-2.46
0.48
-1.87
Diluted EPS
0.46
-2.98
-2.46
0.48
-1.87
Basic Average Shares
52,065
70,371
60,761
52,065
41,308
Diluted Average Shares
53,623
70,371
60,761
52,065
41,308
Total Operating Income as Reported
-321,212
-229,954
-151,757
26,220
-71,423
Total Expenses
337,212
229,954
151,757
113,489
72,940
Net Income from Continuing & Discontinued Operation
-297,062
-209,360
-149,338
24,926
-73,158
Normalized Income
-297,062
-209,360
-149,338
24,926
-73,158
Interest Income
24,532
21,163
5,872
403
841
Interest Expense
186
208
3,137
1,899
2,357
Net Interest Income
24,346
20,955
2,735
-1,496
-1,516
EBIT
-296,876
-209,152
-146,201
26,825
-70,801
EBITDA
-296,865
-209,140
-146,168
26,868
-70,712
Reconciled Depreciation
11
12
33
43
89
Net Income from Continuing Operation Net Minority Interest
-297,062
-209,360
-149,338
24,926
-73,158
Normalized EBITDA
-296,865
-209,140
-146,168
26,868
-70,712
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0